These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 35544742)
1. A bacterium-like particle vaccine displaying Zika virus prM-E induces systemic immune responses in mice. Jin H; Bai Y; Wang J; Jiao C; Liu D; Zhang M; Li E; Huang P; Gong Z; Song Y; Xu S; Feng N; Zhao Y; Wang T; Li N; Gao Y; Yang S; Zhang H; Li Y; Xia X; Wang H Transbound Emerg Dis; 2022 Sep; 69(5):e2516-e2529. PubMed ID: 35544742 [TBL] [Abstract][Full Text] [Related]
2. An inactivated recombinant rabies virus displaying the Zika virus prM-E induces protective immunity against both pathogens. Jin H; Jiao C; Cao Z; Huang P; Chi H; Bai Y; Liu D; Wang J; Feng N; Li N; Zhao Y; Wang T; Gao Y; Yang S; Xia X; Wang H PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009484. PubMed ID: 34086672 [TBL] [Abstract][Full Text] [Related]
3. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus. Garg H; Sedano M; Plata G; Punke EB; Joshi A J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019 [TBL] [Abstract][Full Text] [Related]
4. Zika Virus-Like Particles Bearing a Covalent Dimer of Envelope Protein Protect Mice from Lethal Challenge. De Lorenzo G; Tandavanitj R; Doig J; Setthapramote C; Poggianella M; Sanchez-Velazquez R; Scales HE; Edgar JM; Kohl A; Brewer J; Burrone OR; Patel AH J Virol; 2020 Dec; 95(1):. PubMed ID: 33028720 [TBL] [Abstract][Full Text] [Related]
5. A Bacterium-like Particle Vaccine Displaying Envelope Proteins of Canine Distemper Virus Can Induce Immune Responses in Mice and Dogs. Liu L; Wang J; Li R; Wu J; Zhao Y; Yan F; Wang T; Gao Y; Zhao Z; Feng N; Xia X Viruses; 2024 Mar; 16(4):. PubMed ID: 38675892 [TBL] [Abstract][Full Text] [Related]
6. Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage. Xu K; Song Y; Dai L; Zhang Y; Lu X; Xie Y; Zhang H; Cheng T; Wang Q; Huang Q; Bi Y; Liu WJ; Liu W; Li X; Qin C; Shi Y; Yan J; Zhou D; Gao GF J Virol; 2018 Mar; 92(6):. PubMed ID: 29298885 [TBL] [Abstract][Full Text] [Related]
7. Immunization With a Novel Human Type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models. Guo Q; Chan JF; Poon VK; Wu S; Chan CC; Hou L; Yip CC; Ren C; Cai JP; Zhao M; Zhang AJ; Song X; Chan KH; Wang B; Kok KH; Wen Y; Yuen KY; Chen W J Infect Dis; 2018 Jul; 218(3):365-377. PubMed ID: 29617816 [TBL] [Abstract][Full Text] [Related]
8. Maternal immunization with a DNA vaccine candidate elicits specific passive protection against post-natal Zika virus infection in immunocompetent BALB/c mice. Wang R; Liao X; Fan D; Wang L; Song J; Feng K; Li M; Wang P; Chen H; An J Vaccine; 2018 Jun; 36(24):3522-3532. PubMed ID: 29753607 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Zika virus DNA vaccines based on NS1 and domain III of E. Xiong G; Li Y; Chen F; Xiong X; Wang Q; Zhang L; Dong H; Zhu C; Cui J; He M; Cheng H; Hu A; Cheng C; Pang J; Liu G; Chen H Int Immunopharmacol; 2022 Dec; 113(Pt A):109308. PubMed ID: 36274487 [TBL] [Abstract][Full Text] [Related]
10. A Novel Bacterium-Like Particle-Based Vaccine Displaying the SUDV Glycoprotein Induces Potent Humoral and Cellular Immune Responses in Mice. Xu S; Jiao C; Jin H; Li W; Li E; Cao Z; Shi Z; Yan F; Zhang S; He H; Chi H; Feng N; Zhao Y; Gao Y; Yang S; Wang J; Wang H; Xia X Viruses; 2019 Dec; 11(12):. PubMed ID: 31835785 [TBL] [Abstract][Full Text] [Related]
11. The combined vaccination protocol of DNA/MVA expressing Zika virus structural proteins as efficient inducer of T and B cell immune responses. Pérez P; Martín-Acebes MA; Poderoso T; Lázaro-Frías A; Saiz JC; Sorzano CÓS; Esteban M; García-Arriaza J Emerg Microbes Infect; 2021 Dec; 10(1):1441-1456. PubMed ID: 34213405 [TBL] [Abstract][Full Text] [Related]
13. Humoral and cellular immunity against both ZIKV and poxvirus is elicited by a two-dose regimen using DNA and non-replicating vaccinia virus-based vaccine candidates. Zhan Y; Deng Y; Huang B; Song Q; Wang W; Yang Y; Dai L; Wang W; Yan J; Gao GF; Tan W Vaccine; 2019 Apr; 37(15):2122-2130. PubMed ID: 30851967 [TBL] [Abstract][Full Text] [Related]
14. Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor. Dussupt V; Sankhala RS; Gromowski GD; Donofrio G; De La Barrera RA; Larocca RA; Zaky W; Mendez-Rivera L; Choe M; Davidson E; McCracken MK; Brien JD; Abbink P; Bai H; Bryan AL; Bias CH; Berry IM; Botero N; Cook T; Doria-Rose NA; Escuer AGI; Frimpong JA; Geretz A; Hernandez M; Hollidge BS; Jian N; Kabra K; Leggat DJ; Liu J; Pinto AK; Rutvisuttinunt W; Setliff I; Tran U; Townsley S; Doranz BJ; Rolland M; McDermott AB; Georgiev IS; Thomas R; Robb ML; Eckels KH; Barranco E; Koren M; Smith DR; Jarman RG; George SL; Stephenson KE; Barouch DH; Modjarrad K; Michael NL; Joyce MG; Krebs SJ Nat Med; 2020 Feb; 26(2):228-235. PubMed ID: 32015557 [TBL] [Abstract][Full Text] [Related]
15. Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus. Yang M; Dent M; Lai H; Sun H; Chen Q Vaccine; 2017 Jul; 35(33):4287-4294. PubMed ID: 28669618 [TBL] [Abstract][Full Text] [Related]
16. Vesicular Stomatitis Virus and DNA Vaccines Expressing Zika Virus Nonstructural Protein 1 Induce Substantial but Not Sterilizing Protection against Zika Virus Infection. Li A; Xue M; Attia Z; Yu J; Lu M; Shan C; Liang X; Gao TZ; Shi PY; Peeples ME; Boyaka PN; Liu SL; Li J J Virol; 2020 Aug; 94(17):. PubMed ID: 32554698 [TBL] [Abstract][Full Text] [Related]
17. Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses. Tai W; He L; Wang Y; Sun S; Zhao G; Luo C; Li P; Zhao H; Fremont DH; Li F; Jiang S; Zhou Y; Du L Emerg Microbes Infect; 2018 Jan; 7(1):7. PubMed ID: 29362446 [TBL] [Abstract][Full Text] [Related]
19. NS1-based DNA vaccination confers mouse protective immunity against ZIKV challenge. Zhan Y; Pang Z; Du Y; Wang W; Yang Y; Wang W; Gao GF; Huang B; Deng Y; Tan W Infect Genet Evol; 2020 Nov; 85():104521. PubMed ID: 32882433 [TBL] [Abstract][Full Text] [Related]
20. Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge. Espinosa D; Mendy J; Manayani D; Vang L; Wang C; Richard T; Guenther B; Aruri J; Avanzini J; Garduno F; Farness P; Gurwith M; Smith J; Harris E; Alexander J EBioMedicine; 2018 Jan; 27():61-70. PubMed ID: 29269041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]